AU-FDS Electronics and Control System

Added: May 12, 2016 3:44 pm INTRODUCTION

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION.

The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), intends to negotiate and award a purchase order on a noncompetitive sole source basis to Aviv Medical Inc, 750 Vassar Ave, Lakewood, NJ 08701, to procure an AU-FDS Electronics and Control System for NIBIB's Dynamics of Macromolecular Assembly Section.

BACKGROUND

The goal of the Dynamics of Macromolecular Assembly section (DMA), as part of the Laboratory of Cellular Imaging and Macromolecular Biophysics (LCIMB), is the development of biophysical tools for the characterization of reversible macromolecular interactions in biological systems. A significant part of the lab's work is focused on the development and application of methods to characterize thermodynamic and dynamic properties of chemical and biological molecules by analytical ultracentrifugation. This includes research on cutting edge detection approaches such as fluorescence detection for analytical ultracentrifugation. To this end, the lab has previously purchased two AU-FDS optics boxes with different wavelengths, which can be mounted into a dedicated analytical ultracentrifuge equipped with the accessory hardware and software to operate the AU-FDS optics box.

Previously, the lab has embarked on the use of different excitation wavelengths in the fluorescence detection, and for this purpose has previously purchased a second AU-FDS optics box with a 561 nm excitation in addition to the system with 488 nm excitation that the lab already owns. Now the lab has the choice of either carrying out experiments with 488 nm excitation, or with 561 nm excitation. The lab has verified that both excitation wavelengths are very useful, and that the systems operate very well. Therefore, the lab is requesting the purchase of a second AU-FDS Electronics and Control System, so that they can run both optics boxes at the same time in different centrifuges.

PURPOSE

The purpose of this acquisition is to procure an AU-FDS Electronics and Control System for NIBIB's Dynamics of Macromolecular Assembly Section. This system is required by NIBIB to modify an existing analytical ultracentrifuge so that it can accept an existing AU-FDS optics box.

PROCUREMENT

The contractor shall provide the following:

• Vacuum Manifold that provides hermetically sealed electrical connections into the AUC vacuum chamber.
• System Box that includes cables and RS232 Switch Box that provides power for the AU-FDS, processes signals, and serves as an interface between the computer and distribution box.
• Distribution Box that includes cables and interfaces the Systems Box, AUC signals and vacuum manifold.
• Computer System that includes Windows 7 computer, high speed A/D boards, low speed A/D boards and advanced Operating System Software
• Installation
• Travel Expenses

JUSTIFICATION

Based on our market research we have determined that Aviv Biomedical is the sole manufacturer of the hardware and software that is compatible with NIBIB's existing AU-FDS optics boxes. Therefore, they are the only supplier that can fulfill the laboratory's specific requirements for this procurement.

REGULATORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1(b) Soliciting from a single source (for purchases not exceeding the simplified acquisition threshold) and only one responsible source and no other supplies or services will satisfy agency requirements.

ADDITIONAL INFORMATION

Industry Classification (NAICS) Code is 334516, All Other Animal Production, and the Small Business Size Standard is 1000 employees. The acquisition is being conducted under FAR Part 13, Simplified Acquisition Procedures, therefore the requirements of FAR Part 6, Competitive Requirements, are not applicable (FAR Part 6.001). The resultant award will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05-87 (April 6, 2016).

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by May 23, 2016 at 9:00AM EST and must reference synopsis number NHLBI-CSB-(HL)-2016-132-KMA. Responses shall be submitted to the National Heart, Lung, and Blood Institute, Office of Acquisitions, COAC Services Branch, 6701 Rockledge Drive, Room 6127, Bethesda, Maryland 20892-7902, Attention: Kevin Alvarez. Responses may be submitted electronically to kevin.alvarez@nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."